Evidence map›Paper›PMID 26495258›Full record

ArticleInternational journal of high risk behaviors & addiction2015

Effect of Abstinence on Depression, Anxiety, and Quality of Life in Chronic Methamphetamine Users in a Therapeutic Community.

Maryam Bagheri, Azarakhsh Mokri, Aliakbar Khosravi, Kourosh Kabir

Abstract read
In one paragraph

Article in International journal of high risk behaviors & addiction, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Vitamin B12 Levels in Methamphetamine Addicts.Frontiers in behavioral neuroscience · 2018
    Article
  6. The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2017
    Article
  7. Brain Microstructure and Impulsivity Differ between Current and Past Methamphetamine Users.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maryam BagheriCentral Tehran Branch, Islamic Azad University, Tehran, IR Iran.
Azarakhsh MokriClinical Department, Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, IR Iran.
Aliakbar KhosraviCentral Tehran Branch, Islamic Azad University, Tehran, IR Iran.
Kourosh KabirCommunity Medicine Department, School of Medicine, Alborz University of Medical Sciences, Karaj, IR Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring withdrawal, patients experience different symptoms. These symptoms are associated with relapse. Understanding different outcomes of methamphetamine abstinence is useful for finding better treatments for dependence.

objectivesThis study aimed to show the effects of abstinence on depression, anxiety, and quality of life in methamphetamine users. PATIENTS AND

methodsA prospective quasi-experimental (before and after study) method was used to show the effect of 3 weeks abstinence on depression, anxiety, and quality of life. A convenient sample of addicted people entered into the study and 34 people completed the study. Beck Depression Scale, Cattell Anxiety Inventory and Short Form Health Survey (SF-36) (for assessing quality of life), were used for outcome assessments.

resultsThe mean depression score after abstinence decreased significantly (P < 0.001). Both hidden and obvious anxiety and total anxiety had a high level at admission and after 3 weeks of abstinence, the mean level of anxiety did not change significantly (P < 0.096). However, the quality of life increased after 3 weeks of abstinence (P < 0.001).

conclusionsDepression and anxiety are prevalent in methamphetamine users. Short-term abstinence improves depression and quality of life but does not improve anxiety in methamphetamine abusers. During follow up of these patients, addressing depression and anxiety is important to achieve better results.

Indexed as

Amphetamine-Related DisordersAnxietyDepressionMethamphetamineQuality of LifeSubstance Withdrawal Syndrome

Identifiers

PMID26495258
PMCPMC4609503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.